practice · Tracked item
Tumor-infiltrating lymphocyte (TIL) therapy
Every recorded take from the experts Cited tracks — each with the exact quote, source, and timestamp.
▲ Strong endorse
1 recommendation across 1 expert · 1 episode
1 endorse
0 nuanced
0 avoid
Who's on the record
-
Attia is highly optimistic that adoptive cell therapies using TIL and engineered T cells will be able to eradicate most solid organ metastatic cancers within ~10 years.
“designer-based immunotherapies to eradicate most solid organ metastatic cancers
TP▶ 19:00CaveatsCurrently expensive (~$300k); may not be insurance-covered initiallyCertaintyspeculativestrong endorsement